Rilmazafone
Rilmazafone
Rilmazafone (pronounced: ril-maz-uh-fone) is a hypnotic agent used in the treatment of insomnia. It is a prodrug for the active metabolite flunitrazepam.
Etymology
The term "Rilmazafone" is derived from the components of its chemical structure, which include a pyridyl ring (ril), a methyl group (ma), and a benzodiazepine core (zafone).
Pharmacology
Rilmazafone is classified as a benzodiazepine derivative and is marketed in Japan under the brand name Rhythmy. It is a water-soluble prodrug of the benzodiazepine-class drug flunitrazepam. Upon ingestion, rilmazafone is metabolized in the liver into an active form that exerts its effects by binding to the GABA receptor, enhancing the effects of this inhibitory neurotransmitter.
Medical Uses
Rilmazafone is primarily used for the short-term treatment of insomnia, including difficulties with sleep onset and maintenance. It is also occasionally used off-label for the treatment of certain forms of anxiety.
Side Effects
Common side effects of rilmazafone include drowsiness, dizziness, and impaired coordination. Less common side effects can include memory impairment, dependence, and withdrawal symptoms upon abrupt discontinuation.
Related Terms
External links
- Medical encyclopedia article on Rilmazafone
- Wikipedia's article - Rilmazafone
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski